Tresiba Europäische Union - Maltesisch - EMA (European Medicines Agency)

tresiba

novo nordisk a/s - insulina degludec - diabetes mellitus - drogi użati fid-dijabete - trattament tad-dijabete mellitus fl-adulti.

Velosulin Europäische Union - Maltesisch - EMA (European Medicines Agency)

velosulin

novo nordisk a/s - insulin human - diabetes mellitus - drogi użati fid-dijabete - trattament tad-dijabete mellitus.

Xtandi Europäische Union - Maltesisch - EMA (European Medicines Agency)

xtandi

astellas pharma europe b.v. - enzalutamide - neoplasmi prostatiċi - terapija endokrinali - xtandi is indicated for:the treatment of adult men with metastatic hormone-sensitive prostate cancer (mhspc) in combination with androgen deprivation therapy (see section 5. the treatment of adult men with high-risk non-metastatic castration-resistant prostate cancer (crpc) (see section 5. the treatment of adult men with metastatic crpc who are asymptomatic or mildly symptomatic after failure of androgen deprivation therapy in whom chemotherapy is not yet clinically indicated (see section 5. the treatment of adult men with metastatic crpc whose disease has progressed on or after docetaxel therapy.

Alkindi Europäische Union - Maltesisch - EMA (European Medicines Agency)

alkindi

diurnal europe b.v. - hydrocortisone - insuffiċjenza adrenali - kortikosterojdi għal użu sistemiku - terapija tas-sostituzzjoni ta ' insuffiċjenza adrenali fit-trabi, tfal u l-adoloxxenti (mit-twelid sa < 18-il sena).

GHRYVELIN (previously Macimorelin Aeterna Zentaris) Europäische Union - Maltesisch - EMA (European Medicines Agency)

ghryvelin (previously macimorelin aeterna zentaris)

atnahs pharma netherlands b.v. - macimorelin acetate - tekniki dijanjostiċi, endokrinali - macimorelin - dan il-prodott mediċinali huwa għal użu dijanjostiku biss.  ghryvelin is indicated for the diagnosis of growth hormone deficiency (ghd) in adults.

Ayvakyt Europäische Union - Maltesisch - EMA (European Medicines Agency)

ayvakyt

blueprint medicines (netherlands) b.v. - avapritinib - tumur stromali gastrointestinali - aġenti antineoplastiċi oħra, inibituri tal-proteina kinase - ayvakyt is indicated as monotherapy for the treatment of adult patients with unresectable or metastatic gastrointestinal stromal tumours (gist) harbouring the platelet-derived growth factor receptor alpha (pdgfra) d842v mutation.

Ryeqo Europäische Union - Maltesisch - EMA (European Medicines Agency)

ryeqo

gedeon richter plc. - relugolix, norethisterone acetate, estradiol hemihydrate - leiomyoma - ormoni u analogi pitwitarji u ipotalamiċi - ryeqo is indicated in adult women of reproductive age for:- treatment of moderate to severe symptoms of uterine fibroids,- symptomatic treatment of endometriosis in women with a history of previous medical or surgical treatment for their endometriosis.

Efmody Europäische Union - Maltesisch - EMA (European Medicines Agency)

efmody

diurnal europe b.v. - hydrocortisone - adrenal hyperplasia, congenital - kortikosterojdi għal użu sistemiku - treatment of congenital adrenal hyperplasia (cah) in adolescents aged 12 years and over and adults.

Paxlovid Europäische Union - Maltesisch - EMA (European Medicines Agency)

paxlovid

pfizer europe ma eeig - nirmatrelvir, ritonavir - covid-19 virus infection - paxlovid is indicated for the treatment of coronavirus disease 2019 (covid-19) in adults who do not require supplemental oxygen and who are at increased risk for progressing to severe covid 19.

Truvelog Mix 30 Europäische Union - Maltesisch - EMA (European Medicines Agency)

truvelog mix 30

sanofi winthrop industrie - insulin aspart - diabetes mellitus - drogi użati fid-dijabete - truvelog mix 30 is indicated for treatment of diabetes mellitus in adults, adolescents and children aged 10 years and above.